Microdecompression and drugs of ingredients of acetaminophen; codeine phosphate (a real world drug study)
Summary:
There is no Microdecompression reported by people who take drugs with ingredients of acetaminophen; codeine phosphate yet. This review analyzes which people have Microdecompression with drugs with ingredients of acetaminophen; codeine phosphate. It is created by eHealthMe based on reports from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Acetaminophen and codeine phosphate, Capital and codeine, Co-codamol, Codrix, Empracet w/ codeine phosphate #3, Empracet w/ codeine phosphate #4, Papa-deine #3, Papa-deine #4, Phenaphen w/ codeine no. 2, Phenaphen w/ codeine no. 3, Phenaphen w/ codeine no. 4, Phenaphen-650 w/ codeine, Proval #3, Tylenol w/ codeine, Tylenol w/ codeine no. 1, Tylenol w/ codeine no. 2, Tylenol w/ codeine no. 3, Tylenol w/ codeine no. 4.
No report is found.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of acetaminophen; codeine phosphate, their effectiveness, alternatives and more:
- Acetaminophen and codeine phosphate
- Capital and codeine
- Co-codamol
- Codrix
- Empracet w/ codeine phosphate #3
- Empracet w/ codeine phosphate #4
- Papa-deine #3
- Papa-deine #4
- Phenaphen w/ codeine no. 2
- Phenaphen w/ codeine no. 3
- Phenaphen w/ codeine no. 4
- Phenaphen-650 w/ codeine
- Proval #3
- Tylenol w/ codeine
- Tylenol w/ codeine no. 1
- Tylenol w/ codeine no. 2
- Tylenol w/ codeine no. 3
- Tylenol w/ codeine no. 4
How the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; codeine phosphate. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aciphex and Vision - Light Sensitive for Women aged 50-59 - 2 seconds ago
- Valtrex and Nosebleed for Men aged 60+ - 2 seconds ago
- Aciphex and Light Sensitivity for Women aged 50-59 - 2 seconds ago
- Erbitux and Magnesium drug interactions for men aged 50-59 - 2 seconds ago
- Valtrex and Nose Bleed for Men aged 60+ - 3 seconds ago
- Aciphex and Eyes - Sensitive To Light for Women aged 50-59 - 3 seconds ago
- Valtrex and Nosebleeds for Men aged 60+ - 3 seconds ago
- Valtrex and Epistaxis for Men aged 60+ - 3 seconds ago
- Aciphex and Photophobia for Women aged 50-59 - 4 seconds ago
- Valtrex and Bleeding From The Nose for Men aged 60+ - 4 seconds ago